transgenic-mice
(2)
Cyagen Biosciences
Cyagen Biosciences is a life-sciences contract research organization that builds custom genetically engineered rodent models - knockout, knockin, conditional, and humanized mice and rats - for academic labs and drug developers. Founded in 2006 and headquartered in Santa Clara, California, with major operations in China, Japan, and Europe, Cyagen has grown into one of the world's largest suppliers of custom mouse and rat models, complemented by stem-cell products and a fast-growing gene-delivery arm, VectorBuilder, that designs and manufactures viral vectors from research through clinical CDMO work.
Alloy Therapeutics, Inc.
Alloy Therapeutics is a biotechnology ecosystem company that democratizes access to the tools, platforms, and expertise needed to discover and develop new drugs. Founded in 2017 by Errik Anderson and headquartered in the Boston area (Lexington, Massachusetts), Alloy gives more than 200 partners non-exclusive, affordable access to proprietary technologies - led by its royalty-free ATX-Gx transgenic-mouse antibody discovery platform - along with discovery services and a venture studio that builds new biotech companies. Its model is unusual: Alloy reinvests revenue into innovation and its controlling stock cannot be sold. In April 2026 the company raised a $40M Series E at a $1B valuation.